Product Introduction:
Glytrin Met Tablet is a combination of two oral antidiabetic agents: Gliclazide, a sulfonylurea that stimulates insulin secretion from the pancreas, and Metformin, a biguanide that reduces glucose production in the liver and improves insulin sensitivity.
Uses:
-
Type 2 diabetes mellitus
-
Used in patients whose blood sugar is not controlled by diet and exercise alone
Benefits:
-
Dual mechanism for effective blood sugar control
-
Reduces risk of diabetes-related complications
-
Helps maintain HbA1c within target range
Composition:
-
Gliclazide (dosage may vary — commonly 40 or 60 mg)
-
Metformin (usually 500 mg)
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea and vomiting
-
Diarrhea
-
Abdominal discomfort
-
Metallic taste
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood sugar levels regularly
-
Avoid skipping meals to prevent hypoglycemia
-
Inform your doctor if you have kidney, liver, or heart issues
-
Not recommended during pregnancy unless advised by a doctor
